Skip to content

Prevention of loneliness and depression in elderly nursing home patients living in Amsterdam using Life Review Therapy.

Prevention of loneliness and depression in elderly nursing home patients living in Amsterdam using Life Review Therapy.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON26366
Enrollment
100
Registered
2006-12-04
Start date
2007-02-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention: The life review consisted of autobiographical retrieval practice that entailed focusing on a particular life period each week - childhood, adolescence, adulthood, and summary. For each p
depressive symptoms (GDS-8), cognitive functioning (MMSE), MINI-interview (dsm-diagnoses depression and dysthymie), anxiety (HADS), loneliness (De Jong Gierveld Loneliness Scale), Autobiographical Mem

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age over 65; 2. Living in a nursing home; 3. Normal cognitive functioning/ no signs of dementia; 4. No pharmacological treatment.

Exclusion criteria

Exclusion criteria: 1. No or less depressive symptoms; 2. Mild or severe cognitive symptoms.

Design outcomes

Primary

MeasureTime frame
Depression (Griatric Depression Scale-8, MINI-interview) and loneliness (De Jong Gierveld Loneliness Scale). Anxiety, HADS, autobiographical memory(AMT). Posttreatment one or two weeks after ending intervention (4 weeks after inclusion).

Secondary

MeasureTime frame
Analysing the influence of covariates on the outcome of the life review therapy (neuroticism (NEO-FFI), worrying (PSWQ-11), quality of life)/mastery (PMS).

Contacts

Public ContactBas Steunenberg

VU University Medical Center, Department of Clinical Psychology Van der Boechorststraat 1

B.Steunenberg@psy.vu.nl+31 (0)20 5988703

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)